These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19764841)

  • 41. Dose accuracy and injection force of different insulin glargine pens.
    Friedrichs A; Bohnet J; Korger V; Adler S; Schubert-Zsilavecz M; Abdel-Tawab M
    J Diabetes Sci Technol; 2013 Sep; 7(5):1346-53. PubMed ID: 24124963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dosing accuracy and insulin flow rate characteristics of a new disposable insulin pen, FlexTouch, compared with SoloSTAR.
    Bohnet J; Schmitz M; Kamlot S; Abdel-Tawab M
    J Diabetes Sci Technol; 2013 Jul; 7(4):1021-6. PubMed ID: 23911185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Healthcare professional and patient assessment of a new prefilled insulin pen versus two widely available prefilled insulin pens for ease of use, teaching and learning.
    Nadeau DA; Campos C; Niemeyer M; Bailey T
    Curr Med Res Opin; 2012 Jan; 28(1):3-13. PubMed ID: 22114905
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The importance of patient compliance with insulin pens: how can a new user-friendly pen help?
    Pafili K; Papanas N
    Expert Opin Drug Deliv; 2014 May; 11(5):629-32. PubMed ID: 24661150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dosing accuracy of commonly used disposable insulin pens.
    Krzywon M; Abdel-Tawab M; van der Burg T; Fuhr U; Schubert-Zsilavecz M
    Curr Med Res Opin; 2010 Apr; 26(4):901-5. PubMed ID: 20151786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An assessment of dose accuracy and injection force of a novel prefilled insulin pen: comparison with a widely used prefilled insulin pen.
    Wielandt JO; Niemeyer M; Hansen MR; Bucher D; Thomsen NB
    Expert Opin Drug Deliv; 2011 Oct; 8(10):1271-6. PubMed ID: 21883036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Health economics and compliance of vials/syringes versus pen devices: a review of the evidence.
    Asche CV; Shane-McWhorter L; Raparla S
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S101-8. PubMed ID: 20515297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis and perspective of Dosing accuracy and insulin flow rate characteristics of a new disposable insulin pen, FlexTouch, compared with SoloSTAR.
    Yeager HK; Ignaut DA
    J Diabetes Sci Technol; 2013 Jul; 7(4):1027-9. PubMed ID: 23911186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of adherence and healthcare costs of insulin device (FlexPen) versus conventional vial/syringe.
    Baser O; Bouchard J; DeLuzio T; Henk H; Aagren M
    Adv Ther; 2010 Feb; 27(2):94-104. PubMed ID: 20352392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of dose selection attributes with audible notification in insulin pen devices.
    Asakura T; Seino H
    Diabetes Technol Ther; 2005 Aug; 7(4):620-6. PubMed ID: 16120036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FlexTouch: a prefilled insulin pen with a novel injection mechanism with consistent high accuracy at low- (1 U), medium- (40 U), and high- (80 U) dose settings.
    Wielandt JO; Niemeyer M; Hansen MR; Bucher D; Thomsen NB
    J Diabetes Sci Technol; 2011 Sep; 5(5):1195-9. PubMed ID: 22027317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of the injection force of solostar® compared with other disposable insulin pen devices at constant volume flow rates.
    Carter AW
    J Diabetes Sci Technol; 2011 Jan; 5(1):156-7. PubMed ID: 21303638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of the SoloSTAR insulin pen device: design verification and validation.
    Bode A
    Expert Opin Drug Deliv; 2009 Jan; 6(1):103-12. PubMed ID: 19236211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FlexTouch® for the delivery of insulin: technical attributes and perception among patients and healthcare professionals.
    Bailey T; Campos C
    Expert Rev Med Devices; 2012 May; 9(3):209-17. PubMed ID: 22471783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Performance of a new reusable insulin pen.
    Penfornis A
    Diabetes Technol Ther; 2011 Mar; 13(3):373-9. PubMed ID: 21291331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of injection force and dosage scale size between NovoPen 3 and NovoPen 4.
    Donsmark M; Herold L; Kristensen CM
    Diabetes Technol Ther; 2009 Sep; 11(9):581-5. PubMed ID: 19764837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dose accuracy of new versus used Novopen 4 insulin pens.
    Yucel H; Taks M; Menheere P; Grouls R; Bravenboer B
    Diabetes Technol Ther; 2012 Sep; 14(9):810-2. PubMed ID: 22866889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. United States patient preference and usability for the new disposable insulin device Solostar versus other disposable pens.
    Fischer JS; Edelman SV; Schwartz SL
    J Diabetes Sci Technol; 2008 Nov; 2(6):1157-60. PubMed ID: 19885306
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Usability of a pre-filled insulin injection device in a 3-month observational survey of everyday clinical practice in Australia.
    Carter J; Roberts A
    Curr Med Res Opin; 2008 Oct; 24(10):2741-9. PubMed ID: 18715525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The broken pen penalty.
    Lakshmanadoss U; Ayyappan S; Jain A; Konezny M; Rajamani K
    Diabetes Technol Ther; 2010 Mar; 12(3):241-3. PubMed ID: 20151775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.